awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33956485-7DAD4A3D-5154-4591-B96F-6D9DBE11805F
Q33956485-7DAD4A3D-5154-4591-B96F-6D9DBE11805F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33956485-7DAD4A3D-5154-4591-B96F-6D9DBE11805F
Efficacy and safety of golimumab as add-on therapy to disease-modifying antirheumatic drugs: results of the GO-MORE study.
P2860
Q33956485-7DAD4A3D-5154-4591-B96F-6D9DBE11805F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33956485-7DAD4A3D-5154-4591-B96F-6D9DBE11805F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
bd119e8bb88a487f86f4808178e303f2cff54f00
P2860
Golimumab, a human antibody to tumour necrosis factor {alpha} given by monthly subcutaneous injections, in active rheumatoid arthritis despite methotrexate therapy: the GO-FORWARD Study.